BioNTech taps Sobi executive Oelkers as its next CEO
Guido Oelkers will guide BioNTech’s ongoing transition into an oncology-focused biotech, while co-founder and longtime leader Ugur Sahin prepares to join a fledgling mRNA startup.
Read the full article on the original site.
Read Full Article